Global Hemostasis Diagnostics Market to Reach $2.7 Billion by 2027 with a 4.8% CAGR - ResearchAndMarkets.com

The "Hemostasis Diagnostics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Global Hemostasis Diagnostics Market to Reach $2.7 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Hemostasis Diagnostics estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at a CAGR of 4.8% over the analysis period 2020-2027. Prothrombin Test Time (PT), one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$1.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the D Dimer segment is readjusted to a revised 5.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $535.9 Million, While China is Forecast to Grow at 8.5% CAGR

The Hemostasis Diagnostics market in the U.S. is estimated at US$535.9 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$561.5 Million by the year 2027 trailing a CAGR of 8.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2% and 4.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$354.1 Million by the year 2027.

Fibrinogen Segment to Record 4.9% CAGR

In the global Fibrinogen segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$250.4 Million in the year 2020 will reach a projected size of US$339.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 6% CAGR through the analysis period.

Select Competitors (Total 46 Featured) -

  • Abbott Laboratories
  • Alere, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Grifols SA
  • Instrumentation Laboratory
  • Nihon Kohden Corporation
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Hemostasis Diagnostics - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

Companies Mentioned

  • Abbott Laboratories
  • Alere, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Grifols SA
  • Instrumentation Laboratory
  • Nihon Kohden Corporation
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/2hhe61

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com



For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.